Invesaro

Stocks Comparison

Integer vs TransMedics: revenue, profit, margins and growth compared

Integer brought in $1.9B of revenue in fiscal 2025, TransMedics $605.5M in fiscal 2025. Revenue changed by +8.0% at Integer and +37.1% at TransMedics on the year before, so TransMedics grew faster. Integer kept 5.5% of its revenue as net profit, TransMedics 31.4%. Free cash flow was $105.1M at Integer and $133.6M at TransMedics.

Side by side, latest fiscal year

ITGRTMDX
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$1.9B$605.5M
Revenue growth+8.0%+37.1%
Net income$102.8M$190.3M
Net margin5.5%31.4%
Free cash flow$105.1M$133.6M
Free cash flow margin5.7%22.1%
Earnings per share (diluted)$2.89$4.87
Cash$17.2M$488.9M
Debt$1.2B$10M
Price to earnings43.717.5
Market value$4.3B$3B
Dividend yieldn/an/a
Rank by revenue in sector#114 of 523 · Health care#182 of 523 · Health care

Over the years

Revenue
ITGR FY2018: $1.2BITGR FY2019: $1.3BITGR FY2020: $1.1BITGR FY2021: $1.2BITGR FY2022: $1.3BITGR FY2023: $1.6BITGR FY2024: $1.7BITGR FY2025: $1.9BTMDX FY2019: $14.7MTMDX FY2019: $25.8MTMDX FY2020: $28.4MTMDX FY2021: $31.4MTMDX FY2022: $93.5MTMDX FY2023: $241.6MTMDX FY2024: $441.5MTMDX FY2025: $605.5MFY18FY19FY20FY21FY22FY23FY24FY25
ITGR $1.9BTMDX $605.5M
Net income
ITGR FY2018: $168MITGR FY2019: $96.3MITGR FY2020: $77.3MITGR FY2021: $96.8MITGR FY2022: $66.4MITGR FY2023: $90.7MITGR FY2024: $119.9MITGR FY2025: $102.8MTMDX FY2019: -$23.8MTMDX FY2019: -$33.5MTMDX FY2020: -$28.7MTMDX FY2021: -$44.2MTMDX FY2022: -$36.2MTMDX FY2023: -$25MTMDX FY2024: $35.5MTMDX FY2025: $190.3MFY18FY19FY20FY21FY22FY23FY24FY25
ITGR $102.8MTMDX $190.3M
Net margin
ITGR FY2018: 13.8%ITGR FY2019: 7.7%ITGR FY2020: 7.2%ITGR FY2021: 7.9%ITGR FY2022: 5.0%ITGR FY2023: 5.8%ITGR FY2024: 7.0%ITGR FY2025: 5.5%TMDX FY2019: -162.1%TMDX FY2019: -129.8%TMDX FY2020: -101.4%TMDX FY2021: -140.9%TMDX FY2022: -38.8%TMDX FY2023: -10.4%TMDX FY2024: 8.0%TMDX FY2025: 31.4%FY18FY19FY20FY21FY22FY23FY24FY25
ITGR 5.5%TMDX 31.4%
Revenue growth
ITGR FY2019: +3.5%ITGR FY2020: -14.7%ITGR FY2021: +13.8%ITGR FY2022: +9.0%ITGR FY2023: +16.9%ITGR FY2024: +10.3%ITGR FY2025: +8.0%TMDX FY2019: +76.3%TMDX FY2020: +9.7%TMDX FY2021: +10.7%TMDX FY2022: +197.8%TMDX FY2023: +158.5%TMDX FY2024: +82.7%TMDX FY2025: +37.1%FY19FY20FY21FY22FY23FY24FY25
ITGR +8.0%TMDX +37.1%
Free cash flow
ITGR FY2018: $122.4MITGR FY2019: $117.2MITGR FY2020: $134.5MITGR FY2021: $103.2MITGR FY2022: $41.7MITGR FY2023: $60.3MITGR FY2024: $99.8MITGR FY2025: $105.1MTMDX FY2019: -$26.4MTMDX FY2019: -$32.5MTMDX FY2020: -$30.7MTMDX FY2021: -$32.4MTMDX FY2022: -$57.7MTMDX FY2023: -$164.9MTMDX FY2024: -$80.9MTMDX FY2025: $133.6MFY18FY19FY20FY21FY22FY23FY24FY25
ITGR $105.1MTMDX $133.6M

Fiscal years as each company reports them; the two may end in different months.

Questions about Integer and TransMedics

Which is bigger by revenue, Integer or TransMedics?

Integer is bigger by revenue: $1.9B in fiscal 2025, against $605.5M for TransMedics in fiscal 2025.

Which keeps more of its revenue as profit, Integer or TransMedics?

Integer had a net margin of 5.5% in fiscal 2025; TransMedics had 31.4% in fiscal 2025.

Which grew revenue faster, Integer or TransMedics?

In their latest fiscal years revenue changed by +8.0% at Integer and +37.1% at TransMedics.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies